SCHEMBL3674042

SCHEMBL3674042

CC(CCC(=O)O)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
NPC1 O15118 1/20 0.43
KDM4E B2RXH2 1/20 0.42
HTT P42858 1/20 0.42
EPHX2 P34913 5/20 0.42
GABRP O00591 2/20 0.41
GABRD O14764 2/20 0.41
GABRA1 P14867 2/20 0.41
GABRB1 P18505 2/20 0.41
GABRG2 P18507 2/20 0.41
GABRB3 P28472 2/20 0.41
GABRA5 P31644 2/20 0.41
GABRA3 P34903 2/20 0.41
GABRA2 P47869 2/20 0.41
GABRB2 P47870 2/20 0.41
GABRA4 P48169 2/20 0.41
GABRE P78334 2/20 0.41
GABRA6 Q16445 2/20 0.41
GABRG1 Q8N1C3 2/20 0.41
GABRG3 Q99928 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8097536 0.81 ALDH1A1 (0.46) ALDH1A1NPC1EPHX2SLC22A2SLC47A1
SCHEMBL28310832 0.78 KDM4E (0.42) ALDH1A1NPC1KDM4EHTTEPHX2
SCHEMBL28310872 0.77 KDM4E (0.42) ALDH1A1NPC1KDM4EHTTEPHX2
SCHEMBL136083 0.74 SLC22A2 (0.48) ALDH1A1NPC1HTTEPHX2SLC22A2
SCHEMBL332874 0.71 EPHX2 (0.43) ALDH1A1NPC1EPHX2SLC22A2SLC47A1
SCHEMBL14695859 0.71 SLC22A2 (0.50) ALDH1A1NPC1EPHX2SLC22A2SLC47A1
SCHEMBL135697 0.71 SLC22A2 (0.45) ALDH1A1NPC1EPHX2SLC22A2SLC47A1
Rimantadine SCHEMBL9091299 0.70 SLC22A2 (0.67) ALDH1A1NPC1EPHX2SLC22A2SLC47A1
SCHEMBL4075793 0.70 EPHX2 (0.72) ALDH1A1NPC1HTTEPHX2MEN1
SCHEMBL1089252 0.70 ALDH1A1 (0.50) ALDH1A1NPC1EPHX2SLC22A2SLC47A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1149826-B1 Ester compounds having alicyclic structure, and methods for preparing the same SHINETSU CHEMICAL CO (JP) 2010-11-24 EP disclosed
US-6403823-B2 Ester compounds having alicyclic structure and method for preparing same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2002-06-11 US disclosed
US-6403822-B2 NUCLEOPHILIC ADDITION OF ALICYCLIC CARBONYL AND METAL ENOLATE OF ACETATE; POLYCARBON MONOMERS FOR PHOTORESISTS; HIGH REACTIVITY AND SUBSTRATE AFFINITY SHIN-ETSU CHEMICAL, CO., LTD. (JP) 2002-06-11 US disclosed
US-20010051741-A1 Novel ester compounds having alicyclic structure and method for preparing same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2001-12-13 US disclosed
US-20010051742-A1 Novel ester compounds having alicyclic structure and method for preparing same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2001-12-13 US disclosed
EP-1149826-A2 Ester compounds having alicyclic structure, and methods for preparing the same Shin-Etsu Chemical Co., Ltd. (JP) 2001-10-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010051742-A1 Novel ester compounds having alicyclic structure and method for preparing same ARCN1, ECH1, GAR1 ALDH1A1 460/4885NPC1 334/4885KDM4E 876/4885
US-20010051741-A1 Novel ester compounds having alicyclic structure and method for preparing same ARCN1, ECH1, ASIC1 ALDH1A1 421/4885NPC1 718/4885KDM4E 795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.